Posts by: Ana Pena

News

IFN-alpha Kinoid, an investigational vaccine by Neovacs, has a favorable safety profile and showed encouraging signs of effectiveness in systemic lupus erythematosus (SLE) patients, according to results from a Phase 2b clinical ... Read more

June 18, 2018

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

News

Lower testosterone levels might be the reason behind why women are at a higher risk than men of developing autoimmune diseases like lupus, new research suggests. Using animal models, ... Read more

May 7, 2018

New Pathway Behind Lupus and Autoimmunity Discovered in Animal Study

News

A new mechanism that helps to maintain immune self-tolerance and prevent autoimmune diseases was discovered using human cells and mice, new research shows. The findings identify a novel pathway ... Read more

April 25, 2018

Epstein-Barr Infection Raises Risk of Lupus, 6 Other Autoimmune Diseases, Study Suggests

News

Infection with the Epstein-Barr virus (EBV) that causes mononucleosis can increase a person’s risk of developing any of seven major autoimmune diseases, including systemic lupus erythematosus, new and possibly ... Read more

April 13, 2018April 13, 2018

Lenabasum, Investigational Therapy for Lupus, Advances to Phase 2 Clinical Trial

News

A Phase 2 clinical trial testing a Corbus Pharmaceuticals’ synthetic cannabinoid derivative – lenabasum (JBT-101) – for lupus patients is underway. The therapy has no psychotropic properties and is intended ... Read more

Posts by: Ana Pena

Ana Pena

Neovacs’ Investigational Lupus Vaccine Shows Positive Results in Phase 2b Trial

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

New Pathway Behind Lupus and Autoimmunity Discovered in Animal Study

Epstein-Barr Infection Raises Risk of Lupus, 6 Other Autoimmune Diseases, Study Suggests

Lenabasum, Investigational Therapy for Lupus, Advances to Phase 2 Clinical Trial

Pin It on Pinterest